348 related articles for article (PubMed ID: 8681352)
21. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
22. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents.
Bahrke MS; Yesalis CE; Brower KJ
Child Adolesc Psychiatr Clin N Am; 1998 Oct; 7(4):821-38. PubMed ID: 9894044
[TBL] [Abstract][Full Text] [Related]
23. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
24. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
25. American College of Sports Medicine. Position statement on the use and abuse of anabolic-androgenic steroids in sports.
Med Sci Sports; 1977; 9(4):xi-xii. PubMed ID: 604712
[No Abstract] [Full Text] [Related]
26. [Abuse of doping preparations outside organized sports. A new challenge for health care].
Haug E
Tidsskr Nor Laegeforen; 1994 Feb; 114(4):424-5. PubMed ID: 8009474
[No Abstract] [Full Text] [Related]
27. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
Curry LA; Wagman DF
Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
[TBL] [Abstract][Full Text] [Related]
28. [Anabolic steroids in athletes].
Yesalis CE; Wright JE; Lombardo JA
Wien Med Wochenschr; 1992; 142(14):298-308. PubMed ID: 1441566
[TBL] [Abstract][Full Text] [Related]
29. Adverse effects of anabolic steroids in athletes. A constant threat.
Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
[TBL] [Abstract][Full Text] [Related]
30. Medical complications of anabolic steroids.
Feller AA; Mylonakis E; Rich JD
Med Health R I; 2002 Nov; 85(11):338-40. PubMed ID: 12462865
[No Abstract] [Full Text] [Related]
31. [Estimated consumption of anabolic steroids among athletes in Denmark].
Fauner M; Kisling A; Nielsen SL
Nord Med; 1995; 110(1):23-5. PubMed ID: 7831105
[TBL] [Abstract][Full Text] [Related]
32. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.
Pärssinen M; Kujala U; Vartiainen E; Sarna S; Seppälä T
Int J Sports Med; 2000 Apr; 21(3):225-7. PubMed ID: 10834358
[TBL] [Abstract][Full Text] [Related]
33. American College of Sports Medicine position stand on the use of anabolic-androgenic steroids in sports.
Med Sci Sports Exerc; 1987 Oct; 19(5):534-9. PubMed ID: 3316907
[No Abstract] [Full Text] [Related]
34. [Side-effects and doping control of anabolic steroids].
Jensen LK
Ugeskr Laeger; 1994 Oct; 156(40):5872-3. PubMed ID: 7985283
[TBL] [Abstract][Full Text] [Related]
35. Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism.
Pirola I; Cappelli C; Delbarba A; Scalvini T; Agosti B; Assanelli D; Bonetti A; Castellano M
Fertil Steril; 2010 Nov; 94(6):2331.e1-3. PubMed ID: 20416868
[TBL] [Abstract][Full Text] [Related]
36. Anabolic steroids: what should the emergency physician know?
Brown JT
Emerg Med Clin North Am; 2005 Aug; 23(3):815-26, ix-x. PubMed ID: 15982547
[TBL] [Abstract][Full Text] [Related]
37. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
Yesalis CE
AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
[TBL] [Abstract][Full Text] [Related]
38. Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study.
van Breda E; Keizer HA; Kuipers H; Wolffenbuttel BH
Int J Sports Med; 2003 Apr; 24(3):195-6. PubMed ID: 12740738
[TBL] [Abstract][Full Text] [Related]
39. [Use of anabolic androgenic steroids, growth hormone and erythropoietin by patients in general practice].
Keld DB; Hahn T
Ugeskr Laeger; 2006 Sep; 168(37):3121-4. PubMed ID: 16999915
[TBL] [Abstract][Full Text] [Related]
40. Nutritional supplements cross-contaminated and faked with doping substances.
Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
